Benzinga | Jul 28, 2021 07:11AM EDT

Teva Pharmaceutical Indus Q2 EPS $0.59, Inline, Sales $3.91B Miss $4.04B Estimate; Cuts Guidance

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.59 per share which met the analyst consensus estimate. This is a 7.27 percent increase over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $3.91 billion which missed the analyst consensus estimate of $4.04 billion by 3.22 percent. This is a 1.03 percent increase over sales of $3.87 billion the same period last year.